With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...